Clinical significance of pre- and 1-year post-transplant serum ferritin among adult transplant recipients

References

• Armand P, Kim HT, Cutler CS, et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007;109:4586–4588.
   PubMed Web of Science ®Google Scholar
• Maradei SC, Maiolino A, de Azevedo AM, et al. Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. Blood 2009;114:1270–1275.
   PubMed Web of Science ®Google Scholar
• Mahindra A, Bolwell B, Sobecks R, et al. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft- versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation. Br J Haematol 2009;146: 310–316.
   PubMed Web of Science ®Google Scholar
• Kataoka K, Nannya Y, Hangaishi A, et al. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009;15:195–204.
   PubMed Web of Science ®Google Scholar
• Majhail NS, Lazarus HM, Burns LJ. Iron overload in hematopoietic cell transplantation. Bone Marrow Transplant 2008;41:997–1003
   PubMed Web of Science ®Google Scholar
• Tachibana T, Tanaka M, Takasaki H, et al. Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies. Int J Hematol 2011;93:368–374.
   PubMed Web of Science ®Google Scholar
• Tachibana T, Takasaki H, Tanaka M, et al. Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome. Bone Marrow Transplant 2011;46:150–151.
   PubMed Web of Science ®Google Scholar
• Rizzo JD, Wingard JR, Tichelli A, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT). Bone Marrow Transplant 2006;37:249–261.
   PubMed Web of Science ®Google Scholar
• Goto T, Ikuta K, Inamoto Y, et al. Hyperferritinemia after adult allogeneic hematopoietic cell transplantation:quantification of iron burden by determining non-transferrin-bound iron. Int J Hematol 2013;97:125–134.
   PubMed Web of Science ®Google Scholar
• Goldberg SL, Elmann M, Kaminetzky M, et al. One-year post-transplant serum ferritin level is a predictor of long-term survival following allogeneic transplantation. Blood 2010;116(Suppl. 1): Abstract 3453.
   Google Scholar
• Chotsampancharoen T, Gan K, Kasow KA, et al. Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation. Pediatr Transplant 2009;13:348–352.
   PubMed Web of Science ®Google Scholar
• Efebera Y, Saliba RM, Thandi RS, et al. Impact of pre-stem cell transplant ferritin levels on late transplant complications. A landmark analysis to determine potential role of iron chelation in improving transplant outcomes.Biol Blood Marrow Transplant 2009; 15:S92–S93.
   PubMed Web of Science ®Google Scholar
• Meyer SC, O’Meara A, Buser AS, et al. Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2013;19:440–444.
   PubMed Web of Science ®Google Scholar
• Fujimaki K, Taguchi J, Fujita H, et al. Thiotepa/cyclophosphamide/TBI as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome. Bone Marrow Transplant 2004;33:789–792.
   PubMed Web of Science ®Google Scholar
• Przepiorka D, Weisdorf D, Martin P, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995;15:825–828.
   PubMed Web of Science ®Google Scholar
• Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204–217.
   PubMed Web of Science ®Google Scholar
• Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 2013;48:452–458.
   PubMed Web of Science ®Google Scholar
• Tachibana T, Tanaka M, Yamazaki E, et al. Multicenter validation of scoring system of pre-transplant serum ferritin and disease risk in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplant. Leuk Lymphoma 2013;54:1318–1320.
   PubMed Web of Science ®Google Scholar
• Tachibana T, Takasaki H, Tanaka M, et al. Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome. Bone Marrow Transplant 2011;46:150–151.
   PubMed Web of Science ®Google Scholar
• Pullarkat V. Iron overload in patients undergoing hematopoietic stem cell transplantation. Adv Hematol 2010;2010. pii: 345756.
   PubMedGoogle Scholar
• Brissot E, Savani BN, Mohty M. Management of high ferritin in long-term survivors after hematopoietic stem cell transplantation. Semin Hematol 2012;49:35–42.
   PubMed Web of Science ®Google Scholar
• Artz AS, and van Besien K. Pre-transplant serum ferritin is prognostic but is it useful?Leuk Lymphoma 2013;54:1133–1134.
   PubMed Web of Science ®Google Scholar
• Armand P, Kim HT, Rhodes J, et al. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation. Biol Blood Marrow Transplant 2011; 17:852–860.
   PubMed Web of Science ®Google Scholar
• Eisfeld AK, Westerman M, Krahl R, et al. Highly elevated serum hepcidin in patients with acute myeloid leukemia prior to and after allogeneic hematopoietic cell transplantation: does this protect from excessive parenchymal iron loading?Adv Hematol 2011;2011:491058.
   PubMedGoogle Scholar
• Bazuaye GN, Buser A, Gerull S, et al. Prognostic impact of iron parameters in patients undergoing allo-SCT. Bone Marrow Transplant 2012;47:60–64.
   PubMed Web of Science ®Google Scholar
• Wermke M, Schmidt A, Middeke JM, et al. MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation. Clin Cancer Res 2012;18:6460–6468.
   PubMed Web of Science ®Google Scholar